CIK 0001736243 · <br>Emerging growth company
Acurx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ACXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-533-1469
- Business address
- 259 LIBERTY AVENUE, STATEN ISLAND, NY, 10305
- Former names
- Acurx Pharmaceuticals, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-01 | Scodari Joseph C Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2021-07-01 | Sailer Carl Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2021-07-01 | HARRISON THOMAS L Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2021-07-01 | Donohue James J. Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2021-07-01 | DEAN JACK H Director | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2021-07-01 | LUCI DAVID P President and CEO | Grant or award · Stock Option | +500,000 | 500,000 | ||
| 2021-07-01 | Shawah Robert G. Chief Financial Officer | Grant or award · Stock Option | +200,000 | 200,000 | ||
| 2021-07-01 | DELUCCIA ROBERT J Director | Grant or award · Stock Option | +500,000 | 500,000 | ||
| 2021-06-29 | Sailer Carl Director | Purchase | +12,500 | $6.00 | $75K | 67,917 |
| 2021-06-29 | LUCI DAVID P President and CEO | Grant or award · Stock Option | +350,000 | 350,000 | ||
| 2021-06-29 | Shawah Robert G. Chief Financial Officer | Grant or award · Stock Option | +70,000 | 70,000 | ||
| 2021-06-29 | DELUCCIA ROBERT J Director | Grant or award · Stock Option | +350,000 | 350,000 |
Page 4 of 4 · 72 trades